Unibest
← Back to patent-cliff list

CAS 72155-45-4

(S)-tert-butyl (1-oxo-3-phenylpropan-2-yl)carbamate

Codes: ATAZ-025, RITO-038

Application context (from source-drug indications)

HIV infectionAtazanavir Sulfate/CobicistatChronic hepatitis CParitaprevir/Ombitasvir/RitonavirHepatitis CParitaprevir/Ombitasvir/RitonavirDecompensated cirrhosisParitaprevir/Ombitasvir/RitonavirRenal impairmentParitaprevir/Ombitasvir/RitonavirFibrosisParitaprevir/Ombitasvir/RitonavirEnd-stage renal diseaseParitaprevir/Ombitasvir/RitonavirHIV infectionDarunavir Ethanolate/RitonavirHIV infectionRitonavirKaposi's sarcomaRitonavirBreast cancerRitonavirHIV infectionAtazanavir SulfateAcquired immunodeficiency syndromeAtazanavir SulfateMycobacterium tuberculosis infectionAtazanavir SulfateType 1 diabetesAtazanavir Sulfate

Source drugs (routes using this intermediate)

DrugTierExpiry
Atazanavir Sulfate/CobicistatTier C — Watch / trade-
Paritaprevir/Ombitasvir/RitonavirTier C — Watch / trade-
Darunavir Ethanolate/RitonavirTier C — Watch / trade-
RitonavirTier C — Watch / trade-
Atazanavir SulfateTier B — Position early-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.